Journals / Türk Patoloji Dergisi / 2013 / Cilt: 29 - Sayı: 3

Türkiye’deki hpv tipleri: Türk jinekolojik onkoloji grubuna üye merkezlere başvuran 6388 hastanın retrospektif analizi

HPV types in Turkey: Multicenter hospital Based evaluation of 6388 patients in Turkish gynecologic oncology group centers

Pages
210–216
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Overall, 25% of the women were found to be HPV positive.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective:To evaluate the prevalence of HPV DNA and cervical cytological abnormalities, to compare cervical cytology results and HPV DNA and to define HPV types distribution in a large series of Turkish women who have undergone HPV analysis in hospitals that are members of the Turkish Gynecological Oncology Group.
📊
Key Findings & Data:Material and Method:Between 2006 and 2010, a total of 6388 patients’ data was retrospectively evaluated at 12 healthcare centers in Turkey.
💡
Conclusion & Impact:Overall, 25% of the women were found to be HPV positive.
🔬Design:Research Article
📍Scope:2006 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective:To evaluate the prevalence of HPV DNA and cervical cytological abnormalities, to compare cervical cytology results and HPV DNA and to define HPV types distribution in a large series of Turkish women who have undergone HPV analysis in hospitals that are members of the Turkish Gynecological Oncology Group. Material and Method:Between 2006 and 2010, a total of 6388 patients’ data was retrospectively evaluated at 12 healthcare centers in Turkey. Demographic characteristics, cervical cytology results, HPV status and types were compared.Results:The mean age of the patients was 38.9±10.2. Overall, 25% of the women were found to be HPV positive. Presence of HPV-DNA among patients with abnormal and normal cytology was 52% and 27%, respectively. There was significant diff erence with respect to decades of life and HPV positivity (p < 0.05). HPV was positive in(within the HPV (+) patients) 37%, 9%, 27%, 20%, 22%, and 41% of the ASCUS, ASC-H, LSIL HSIL, glandular cell abnormalities, and SCC cases respectively The most common HPV types in our study were as follows; HPV 16 (32%), HPV 6 (17%), HPV 11 (9%), HPV 18 (8%), HPV 31 (6%), HPV 51 (5%), HPV 33 (3%). Conclusion:In this hospital based retrospective analysis, HPV genotypes in Turkish women with normal and abnormal cytology are similar to those reported from western countries. Further population based prospective multicenter studies are necessary to determine non-hospital based HPV prev alence in Turkish women

Özet

Amaç:Türkiyedeki HPV tiplerinin geniş bir seri ile ortaya konması amacı ile Türk Jinekolojik Onkoloji grubuna üye hastanelerde HPV analizi yapılan hastaların sonuçlarının retrospektif olarak değerlendirilmesi ve sitolojik anormalliklerdeki HPV tiplerinin belirlenmesi.Gereç ve Yöntem:2006 ve 2010 yılları arasında 12 ayrı merkeze başvuran smear ve HPV analizi yapılan toplam 6388 hasta retrospektif olarak incelenmiştir. Hastaların demografik bilgileri, smear sonuçları, HPV tipleri online olarak toplanıp analiz edilmiştir. Bulgular:Ortalama hasta yaşı 38.9±10.2 idi. Tüm grup değerlendiril- diğinde, %25 hastada HPV pozitif olarak saptandı. Anormal sitolojisi olanlarda HPV pozitifliği %57 iken normal pap testi olanlarda HPV pozitifliği %27 oranında tespit edildi.Hastaların yaşam dekadları ile HPV pozitifliği arasında anlamlı bir ilişki bulundu (p

🔖

Cite This Article

ALANBAY, İ., KESKİN, L., HABERAL, A., ONAN, A., ÜSTÜNER, I., TAŞKIRAN, Ç., HARMA, M., ERGÜN, Y., AYDOĞMUŞ, H., YENEN, M., ÇAĞLAR, M., YETİMALAR, H., ŞEHİRALİ, S., GÜNER, H., AVŞAR, F., ÖZAT, M., BASARAN, M., SALMAN, M. C., METİNDİR, J., MUTLU, L., Emre, E. (2022). Türkiye’deki hpv tipleri: Türk jinekolojik onkoloji grubuna üye merkezlere başvuran 6388 hastanın retrospektif analizi. Türk Patoloji Dergisi, Cilt: 29 - Sayı: 3, 210–216. https://ajindex.com/articles/640671

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Armstrong EP:Prophylaxis of cervical cancer and related cervical disease: A review of the cost-effectiveness of vaccination against oncogenic HPV types. Journal of Managed Care Pharmacy 2010, 16: 217–230 2. World Health Organization (February 2006). Fact sheet No. 297: Cancer. Retrieved 2007-12-01 3. GLOBOCAN 2002 [database online]: Summary table by cancer. Archived from the original on 2008-06-16. Retrieved 2008-10-26 4. NCCC National Cervical Cancer Coalition. Archived from the original on 2008-08-22. Retrieved 2008-07-01 5.Canavan TP, Doshi NR:Cervical cancer. Am Fam Physician 2000, 61: 1369–1376 6.Dursun P, Senger SS, Arslan H, Kuşçu E, Ayhan A:Human papillomavirus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis 2009, 9:191 7.Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N; Forum Group Members; Bethesda 2001 Workshop: The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002, 287:2114–2119 8.Evans MF, Adamson CS, Papillo JL, St John TL, Leiman G, Cooper K:Distribution of human papillomavirus types in thinprep papanicolaou tests classifi ed according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 2006, 106:1054-1064 9. World Health Organization, Human papillomaviruses Interna- tional Agency for Research on Cancer 2007. ISBN 978-92-832- 1290-4 10.Marrazzo JM, Koutsky LA, Kiviat NB, Kuypers JM, Stine K: Papanicolaou test screening and prevalence of genital human papillomavirus among women who have sex with women. Am J Public Health 2001, 91: 947–952 11.Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ: Epidemiologic classifi cation of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348: 518–527 12.Inal MM, Köse S, Yildirim Y, Ozdemir Y, Töz E, Ertopçu K, Ozelmas I, Tinar S:The relationship between human papillomavirus infection and cervical intraepithelial neoplasia in Turkish women. Int J Gynecol Cancer 2007, 7:1266-1270 13. Ozcelik B, Serin IS, Gokahmetoglu S, Basbug M, Erez R: Human papillomavirus frequency of women at low risk of developing cervical cancer: A preliminary study from a Turkish university hospital. Eur J Gynaecol Oncol 2003, 24:157-159 14.Tuncer ZS, Basaran M, Ustaçelebi S, Kuzey GM: High-Risk Human Papilloma Virus (HPV) Infection Determined By Hybrid Capture II Assay in a T